A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder. How the meds work in the brain.

A breakthrough study reveals that semaglutide, found in Ozempic and Wegovy, could help reduce alcohol cravings and heavy drinking episodes in adults.

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just curb their desire to eat; for some, they also lead them to drink less alcohol.

New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption.

Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use disorder, a new study suggests.

People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol. A new study confirms there's likely something to the anecdotes, with a staggering 30 percent reduction in alcohol consumption per drinking day for those given the medication,

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.